Urokinase-type plasminogen activator and its inhibitor plasminogen activator inhibitor-1: New functional risk factors in head and neck squamous cell cancer

Medizin & Biologie

• Plasminogen Inactivators 100%
• Squamous Cell Neoplasms 93%
• Urokinase-Type Plasminogen Activator 84%
• Plasminogen Activator Inhibitor 1 84%
• Head and Neck Neoplasms 75%
• Head 54%
• Neoplasms 19%
• Biopsy 18%
• Plasminogen Activators 17%
• Serine Proteases 16%
• Mouth Mucosa 16%
• Proteolysis 14%
• Squamous Cell Carcinoma 12%
• Mucous Membrane 11%
• Neck 11%
• Enzyme-Linked Immunosorbent Assay 10%
• Regression Analysis 9%
• Neoplasm Metastasis 9%
• Recurrence 8%
• Proteins 5%